Last update :
19/11/2024
Thrombolytic   Urokinase  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abbokinase Austria, Chile, Spain, Sweden, United States of America
Actosolv Belgium, France, Italy, Luxembourg
Alfakinasi Italy
Angikinase Egypt
Corase Germany
Dabunase India
Dukinase India
KD Unase India
Kisolv Italy
Lynlitic Canada
Medacinase Netherlands
Persolv Italy
Rheotromb Germany
Syner-Kinase Great Britain
Ukidan Greece
Urochinasi Italy
Urokinasa Poland
Urokinase Austria, Germany, Luxembourg, Malaysia, Netherlands, New Zealand, Spain, Switzerland
Uroquidan Spain
Uroquinasa Chile
References   injection   References : Urokinase  
Type Publication
375 Journal Patel JP, Tran LT, Sinai WJ, Carr LJ.
Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes.
Am J Hosp Pharm 1991 ; 48: 1511-1514.
1061 Journal Rhoney DH, Coplin WM, Zaran FK, Brish LK, Weingarten CM.
Urokinase after freezing : Implications for thrombolysis in intraventricular hemorrhage.
Am J Health-Syst Pharm 1999 ; 56: 2047-2051.
1394 Journal Zimmermann R, Sch?ffel G, Harenberg J.
Urokinase therapy: dose reduction by administration in plastic material.
Thromb Haemost 1981 ; 45: 296.
1395 Journal Toki N, Sumi H.
Glass adsorption of highly purified urokinase.
Thromb Haemost 1980 ; 43: 67.
1941 Journal Dedrick SC, Ramirez-Rico J.
Potency and stability of frozen urokinase solutions in syringes.
Am J Health-Syst Pharm 2004 ; 61: 1586-1589.
2050 Journal Kohles JD, Weld M, Asa?d H, Gunning P, Reid Sterrett J, Debari VA.
Stability of reconstituted urokinase solutions.
Current Ther Res 2000 ; 61: 1-6

  Mentions Légales